Medtronic, Inc. (MDT) Tops Q4 EPS by 1c; Guides FY13 Sales
Medtronic, Inc. (NYSE: MDT) reported Q4 EPS of $0.99, $0.01 better than the analyst estimate of $0.98. Revenue for the quarter came in at $4.3 billion versus the consensus estimate of $4.23 billion.
Medtronic, Inc. sees FY2013 EPS of $3.62-$3.70, versus the consensus of $3.66. Sees sales up 2-4 percent.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Medtronic, Inc. sees FY2013 EPS of $3.62-$3.70, versus the consensus of $3.66. Sees sales up 2-4 percent.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.